179 related articles for article (PubMed ID: 36678825)
21. Co-Amorphous Versus Deep Eutectic Solvents Formulations for Transdermal Administration.
Guinet Y; Paccou L; Hédoux A
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376158
[TBL] [Abstract][Full Text] [Related]
22. Vitrification and New Phases in the Water:Pyrimidine Binary Eutectic System.
Patyk-Kaźmierczak E; Podsiadło M; Szafrański M; Katrusiak A
J Phys Chem B; 2019 Aug; 123(33):7190-7196. PubMed ID: 31361487
[TBL] [Abstract][Full Text] [Related]
23. Crystallization of D-mannitol in binary mixtures with NaCl: phase diagram and polymorphism.
Telang C; Suryanarayanan R; Yu L
Pharm Res; 2003 Dec; 20(12):1939-45. PubMed ID: 14725357
[TBL] [Abstract][Full Text] [Related]
24. Study of Thermal Properties, Molecular Dynamics, and Physical Stability of Etoricoxib Mixtures with Octaacetylmaltose near the Glass Transition.
Grzybowska K; Rams-Baron M; Łucak K; Grzybowski A; Paluch M
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077212
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics of amorphous pharmaceutical fenofibrate studied by broadband dielectric spectroscopy.
Sailaja U; Thayyil MS; Kumar NSK; Govindaraj G
J Pharm Anal; 2016 Jun; 6(3):165-170. PubMed ID: 29403977
[TBL] [Abstract][Full Text] [Related]
26. TSDC and DSC Investigation on the Molecular Mobility in the Amorphous Solid State and in the Glass Transformation Region of Two Benzodiazepine Derivatives: Diazepam and Nordazepam.
Diogo HP; Ramos JJM
J Pharm Sci; 2022 Aug; 111(8):2239-2248. PubMed ID: 35235842
[TBL] [Abstract][Full Text] [Related]
27. Molecular Relaxations in Supercooled Liquid and Glassy States of Amorphous Quinidine: Dielectric Spectroscopy and Density Functional Theory Approaches.
Schammé B; Mignot M; Couvrat N; Tognetti V; Joubert L; Dupray V; Delbreilh L; Dargent E; Coquerel G
J Phys Chem B; 2016 Aug; 120(30):7579-92. PubMed ID: 27391029
[TBL] [Abstract][Full Text] [Related]
28. Relation between the alpha-relaxation and Johari-Goldstein beta-relaxation of a component in binary miscible mixtures of glass-formers.
Capaccioli S; Ngai KL
J Phys Chem B; 2005 May; 109(19):9727-35. PubMed ID: 16852172
[TBL] [Abstract][Full Text] [Related]
29. Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.
Queiroz LHS; Barros RS; de Sousa FF; Lage MR; Sarraguça MC; Ribeiro PRS
Mol Pharm; 2024 Mar; 21(3):1272-1284. PubMed ID: 38361428
[TBL] [Abstract][Full Text] [Related]
30. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
31. Correlation between Molecular Mobility and Physical Stability in Pharmaceutical Glasses.
Mehta M; Ragoonanan V; McKenna GB; Suryanarayanan R
Mol Pharm; 2016 Apr; 13(4):1267-77. PubMed ID: 26895136
[TBL] [Abstract][Full Text] [Related]
32. Two glass transitions and secondary relaxations of methyltetrahydrofuran in a binary mixture.
Blochowicz T; Lusceac SA; Gutfreund P; Schramm S; Stühn B
J Phys Chem B; 2011 Feb; 115(7):1623-37. PubMed ID: 21287996
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
34. A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.
Su M; Xia Y; Shen Y; Heng W; Wei Y; Zhang L; Gao Y; Zhang J; Qian S
RSC Adv; 2019 Dec; 10(1):565-583. PubMed ID: 35492562
[TBL] [Abstract][Full Text] [Related]
35. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
Newman A; Reutzel-Edens SM; Zografi G
J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
[TBL] [Abstract][Full Text] [Related]
36. The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations.
Kissi EO; Kasten G; Löbmann K; Rades T; Grohganz H
Mol Pharm; 2018 Sep; 15(9):4247-4256. PubMed ID: 30020794
[TBL] [Abstract][Full Text] [Related]
37. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
Shete G; Khomane KS; Bansal AK
J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
[TBL] [Abstract][Full Text] [Related]
38. Influence of the Internal Structure and Intermolecular Interactions on the Correlation between Structural (α) and Secondary (β-JG) Relaxation below the Glass Transition Temperature in Neat Probucol and Its Binary Mixtures with Modified Saccharides.
Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Kamiński K; Paluch M; Kamińska E
J Phys Chem B; 2020 Jun; 124(23):4821-4834. PubMed ID: 32396358
[TBL] [Abstract][Full Text] [Related]
39. Solid-Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction.
Zemánková A; Hassouna F; Klajmon M; Fulem M
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985463
[TBL] [Abstract][Full Text] [Related]
40. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
Sibik J; Löbmann K; Rades T; Zeitler JA
Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
